DAVID M MOTT Insider Trading $ARDX ARDELYX, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for DAVID M MOTT.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of DAVID M MOTT. DAVID M MOTT is Vice Chairman and CEO in MEDIMMUNE INC /DE ($MEDI) and Director in NOVAVAX INC ($NVAX) and 10% Owner in ARCA biopharma, Inc. ($ABIO) and 10% Owner in INTERLEUKIN GENETICS INC ($ILIU) and 10% Owner in Achaogen Inc ($AKAO) and 10% Owner in AVEO PHARMACEUTICALS INC ($AVEO) and 10% Owner in MULESOFT, INC ($MULE) and 10% Owner in Tracon Pharmaceuticals, Inc. ($TCON) and 10% Owner in Cascadian Therapeutics, Inc. ($CASC) and 10% Owner in Care.com Inc ($CRCM) and Director in ARDELYX, INC. ($ARDX) and 10% Owner in APPIAN CORP ($APPN) and Director in Mersana Therapeutics, Inc. ($MRSN) and 10% Owner in GENOCEA BIOSCIENCES, INC. ($GNCA) and 10% Owner in Roka BioScience, Inc. ($ROKA) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and Director in TESARO, Inc. ($TSRO) and 10% Owner in Regulus Therapeutics Inc. ($RGLS) and 10% Owner in Mirna Therapeutics, Inc. ($MIRN) and 10% Owner in Cerecor Inc. ($CERC) and 10% Owner in Trevi Therapeutics, Inc. ($TRVI) and Director in Epizyme, Inc. ($EPZM) and Director in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and Director in IMARA Inc. ($IMRA) and 10% Owner in Elastic N.V. ($ESTC) and Director in Nightstar Therapeutics plc ($NITE) and 10% Owner in Surface Oncology, Inc. ($SURF) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM).

DAVID M MOTT in ARDELYX, INC.

Trading Symbol: ARDX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: Director
Holdings: 417,284 shares
Current Value: $4,610,988
Latest Transaction: Dec 10 2020
$ARDX Market Capitalization: $529.77M
$ARDX Previous Close: $11.05

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of DAVID M MOTT in ARDELYX, INC.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, AKAO, ADAP, APPN, ABIO, ARDX, AVEO, CRCM, CASC, CERC, ESTC, EPZM, GNCA, IMRA, ILIU, MEDI, MRSN, MIRM, MULE, NITE, NVAX, RARX, RGLS, RYTM, ROKA, SURF, SYBX, TSRO, TCON, TRVI

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Dec 10 2020	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Buy	P	5.89	170,000	1,000,841	417,284	247.3 K to 417.3 K (+68.75 %)
Jun 26 2020	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Buy	P	6.96	68,373	476,040	247,284	178.9 K to 247.3 K (+38.22 %)
Jun 26 2020	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Buy	P	6.75	72,598	489,862	178,911	106.3 K to 178.9 K (+68.29 %)
Jun 24 2020	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Buy	P	6.75	4,673	31,525	106,313	101.6 K to 106.3 K (+4.60 %)
Jun 11 2020	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Option Exercise	A	7.31	75,000	548,250	75,000
Jun 11 2020	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Option Exercise	A	7.31	23,500	171,785	23,500
Jun 11 2020	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Buy	J	0.00	1,079	0	101,640	100.6 K to 101.6 K (+1.07 %)
Jun 11 2020	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Grant	A	0.00	12,995	0	100,561	87.6 K to 100.6 K (+14.84 %)
Dec 09 2019	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Grant	A	6.25	400,000	2,500,000	3,482,186	3.1 M to 3.5 M (+12.98 %)
Jun 17 2019	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Option Exercise	A	2.74	50,000	137,000	50,000
Jun 17 2019	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Grant	A	0.00	32,846	0	87,566	54.7 K to 87.6 K (+60.03 %)
Jun 15 2018	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Option Exercise	A	4.03	15,000	60,450	15,000
Jun 15 2018	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Grant	A	0.00	20,843	0	54,720	33.9 K to 54.7 K (+61.53 %)
May 30 2018	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Grant	A	4.00	416,667	1,666,668	3,082,186	2.7 M to 3.1 M (+15.63 %)
May 30 2018	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Grant	A	4.00	416,666	1,666,664	3,082,186	2.7 M to 3.1 M (+15.63 %)
Jun 09 2017	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Option Exercise	A	4.30	15,000	64,500	15,000
Jun 09 2017	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Grant	A	0.00	19,534	0	33,877	14.3 K to 33.9 K (+136.19 %)
Jul 20 2016	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Buy	P	8.73	763,650	6,666,665	2,665,519	1.9 M to 2.7 M (+40.15 %)
Jul 20 2016	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Buy	P	8.73	763,651	6,666,673	2,665,520	1.9 M to 2.7 M (+40.15 %)
Jul 20 2016	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Buy	P	8.73	763,650	6,666,665	2,665,519	1.9 M to 2.7 M (+40.15 %)
Jul 20 2016	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Buy	P	8.73	763,651	6,666,673	2,665,520	1.9 M to 2.7 M (+40.15 %)
Jun 06 2016	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Option Exercise	A	9.27	15,000	139,050	15,000
Jun 06 2016	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Grant	A	0.00	8,522	0	14,343	5.8 K to 14.3 K (+146.40 %)
Jan 14 2016	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Buy	P	10.00	500,000	5,000,000	1,901,869	1.4 M to 1.9 M (+35.67 %)
Jan 14 2016	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Buy	P	10.00	500,000	5,000,000	1,901,869	1.4 M to 1.9 M (+35.67 %)
Jun 12 2015	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Option Exercise	A	14.60	15,000	219,000	15,000
Jun 12 2015	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Grant	A	0.00	5,821	0	5,821	0 to 5.8 K
Jun 09 2015	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Option Exercise	P	13.91	420,561	5,850,004	420,561
Jun 09 2015	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Option Exercise	P	13.91	420,561	5,850,004	420,561
Jun 09 2015	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Buy	P	10.70	1,401,869	14,999,998	1,401,869	0 to 1.4 M
Jun 09 2015	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Buy	P	10.70	1,401,869	14,999,998	1,401,869	0 to 1.4 M

Page: 1